CENP-A overexpression promotes distinct fates in human cells, depending on p53 status
暂无分享,去创建一个
G. Almouzni | K. Podsypanina | A. Gatto | D. Fachinetti | M. Dumont | Charlène Renaud-Pageot | Daniel Jeffery | L. Bonneville | Rebeca Ponce Landete | Marie Dumont
[1] Maggie,et al. To A∞ And Beyond , 2021, A Gentle Introduction to Homological Mirror Symmetry.
[2] Yael Nechemia-Arbely,et al. Guarding the Genome: CENP-A-Chromatin in Health and Cancer , 2020, Genes.
[3] A. Levine. p53: 800 million years of evolution and 40 years of discovery , 2020, Nature Reviews Cancer.
[4] A. Chinnaiyan,et al. The role of the histone H3 variant CENPA in prostate cancer , 2020, The Journal of Biological Chemistry.
[5] B. Vanderhyden,et al. Context specificity of the EMT transcriptional response , 2020, Nature Communications.
[6] Elaine M. Dunleavy,et al. Asymmetric assembly of centromeres epigenetically regulates stem cell fate , 2020, The Journal of cell biology.
[7] L. Jansen,et al. Reprogramming of human cells to pluripotency induces CENP-A chromatin depletion , 2020, bioRxiv.
[8] Kerstin B. Meyer,et al. BBKNN: fast batch alignment of single cell transcriptomes , 2019, Bioinform..
[9] J. Herman,et al. Epigenetic heterogeneity in cancer , 2019, Biomarker Research.
[10] Fabian J Theis,et al. Generalizing RNA velocity to transient cell states through dynamical modeling , 2019, Nature Biotechnology.
[11] J. Blenis,et al. Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization. , 2019, Cancer cell.
[12] G. Almouzni,et al. Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise , 2019, Nature Reviews Clinical Oncology.
[13] Steven L Salzberg,et al. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype , 2019, Nature Biotechnology.
[14] G. Selivanova,et al. Inhibition of p53 inhibitors: progress, challenges and perspectives , 2019, Journal of molecular cell biology.
[15] Karen H. Miga,et al. DNA replication acts as an error correction mechanism to maintain centromere identity by restricting CENP-A to centromeres , 2019, Nature Cell Biology.
[16] Jing Wang,et al. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs , 2019, Nucleic Acids Res..
[17] S. McClelland,et al. The emerging links between chromosomal instability (CIN), metastasis, inflammation and tumour immunity , 2019, Molecular Cytogenetics.
[18] C. Blanpain,et al. EMT Transition States during Tumor Progression and Metastasis. , 2019, Trends in cell biology.
[19] S. Dimitrov,et al. Centromeric and ectopic assembly of CENP-A chromatin in health and cancer: old marks and new tracks , 2018, Nucleic acids research.
[20] Roderic Guigo,et al. Faculty Opinions recommendation of Scaling single-cell genomics from phenomenology to mechanism. , 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[21] Lior Pachter,et al. The Barcode, UMI, Set format and BUStools , 2018, bioRxiv.
[22] A. Bailey,et al. Inheritance of CENP-A Nucleosomes during DNA Replication Requires HJURP. , 2018, Developmental cell.
[23] D. Sturgill,et al. HJURP antagonizes CENP-A mislocalization driven by the H3.3 chaperones HIRA and DAXX , 2018, PloS one.
[24] T. Reya,et al. Stem cell fate in cancer growth, progression and therapy resistance , 2018, Nature Reviews Cancer.
[25] F. Marcucci,et al. How Tumor Cells Choose Between Epithelial-Mesenchymal Transition and Autophagy to Resist Stress—Therapeutic Implications , 2018, Front. Pharmacol..
[26] G. Mills,et al. Defective Replication Stress Response Is Inherently Linked to the Cancer Stem Cell Phenotype. , 2018, Cell reports.
[27] Sarah M. Regan,et al. Understanding aneuploidy in cancer through the lens of system inheritance, fuzzy inheritance and emergence of new genome systems , 2018, Molecular Cytogenetics.
[28] Eléonore Toufektchan,et al. The Guardian of the Genome Revisited: p53 Downregulates Genes Required for Telomere Maintenance, DNA Repair, and Centromere Structure , 2018, Cancers.
[29] T. Voet,et al. Identification of the tumour transition states occurring during EMT , 2018, Nature.
[30] M. Barton,et al. p53: emerging roles in stem cells, development and beyond , 2018, Development.
[31] B. Edgar,et al. In Vivo Analysis of Centromeric Proteins Reveals a Stem Cell-Specific Asymmetry and an Essential Role in Differentiated, Non-proliferating Cells. , 2018, Cell reports.
[32] G. Blandino,et al. New therapeutic strategies to treat human cancers expressing mutant p53 proteins , 2018, Journal of experimental & clinical cancer research : CR.
[33] A. Puisieux,et al. Cellular Pliancy and the Multistep Process of Tumorigenesis. , 2018, Cancer cell.
[34] K. Wiman,et al. Targeting mutant p53 for efficient cancer therapy , 2017, Nature Reviews Cancer.
[35] T. Steinbichler,et al. Epithelial-mesenchymal crosstalk induces radioresistance in HNSCC cells , 2017, Oncotarget.
[36] Benjamin J. Raphael,et al. The evolutionary history of 2,658 cancers , 2017, Nature.
[37] Fabian J Theis,et al. SCANPY: large-scale single-cell gene expression data analysis , 2018, Genome Biology.
[38] E. Nice,et al. Redox regulation in tumor cell epithelial–mesenchymal transition: molecular basis and therapeutic strategy , 2017, Signal Transduction and Targeted Therapy.
[39] Arunika Das,et al. Centromere inheritance through the germline , 2017, Chromosoma.
[40] J. Wang,et al. Growth-induced stress enhances epithelial-mesenchymal transition induced by IL-6 in clear cell renal cell carcinoma via the Akt/GSK-3β/β-catenin signaling pathway , 2017, Oncogenesis.
[41] William A. Flavahan,et al. Epigenetic plasticity and the hallmarks of cancer , 2017, Science.
[42] C. Abbadie,et al. Epithelial cell senescence: an adaptive response to pre-carcinogenic stresses? , 2017, Cellular and Molecular Life Sciences.
[43] R. Medema,et al. p53 Prohibits Propagation of Chromosome Segregation Errors that Produce Structural Aneuploidies. , 2017, Cell reports.
[44] L. Stanton,et al. Long-Term Culture of Self-renewing Pancreatic Progenitors Derived from Human Pluripotent Stem Cells , 2017, Stem cell reports.
[45] T. Karpova,et al. Mislocalization of centromeric histone H3 variant CENP-A contributes to chromosomal instability (CIN) in human cells , 2017, Oncotarget.
[46] P. Scaffidi,et al. Epigenetics and Cancer Stem Cells: Unleashing, Hijacking, and Restricting Cellular Plasticity , 2017, Trends in cancer.
[47] R. Weinberg,et al. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications , 2017, Nature Reviews Clinical Oncology.
[48] G. Almouzni,et al. Essential role for centromeric factors following p53 loss and oncogenic transformation , 2017, Genes & development.
[49] Iain M Cheeseman,et al. Large-Scale Analysis of CRISPR/Cas9 Cell-Cycle Knockouts Reveals the Diversity of p53-Dependent Responses to Cell-Cycle Defects. , 2017, Developmental cell.
[50] G. Lozano,et al. The Regulation of Cellular Functions by the p53 Protein: Cellular Senescence. , 2017, Cold Spring Harbor perspectives in medicine.
[51] G. Almouzni,et al. Chromatin dynamics during the cell cycle at centromeres , 2017, Nature Reviews Genetics.
[52] A. Desai,et al. A Molecular View of Kinetochore Assembly and Function , 2017, Biology.
[53] Dmitriy Sonkin,et al. TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data , 2016, Human mutation.
[54] Wei Zhu,et al. Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy , 2016, Nature Communications.
[55] Yuzhuo Wang,et al. Elevated expression of the centromere protein‐A(CENP‐A)‐encoding gene as a prognostic and predictive biomarker in human cancers , 2016, International journal of cancer.
[56] A. Heger,et al. UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy , 2016, bioRxiv.
[57] Z. Dong,et al. Chromosome missegregation during anaphase triggers p53 cell cycle arrest through histone H3.3 Ser31 phosphorylation , 2016, Nature Cell Biology.
[58] Lior Pachter,et al. Near-optimal probabilistic RNA-seq quantification , 2016, Nature Biotechnology.
[59] I. Cheeseman,et al. The molecular basis for centromere identity and function , 2015, Nature Reviews Molecular Cell Biology.
[60] Marrije R Buist,et al. Hyperthermia Selectively Targets Human Papillomavirus in Cervical Tumors via p53-Dependent Apoptosis. , 2015, Cancer research.
[61] Andrew P Feinberg,et al. Epigenetics at the Crossroads of Genes and the Environment. , 2015, JAMA.
[62] L. Wessels,et al. Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients , 2015, Clinical Cancer Research.
[63] P. Shah,et al. Regulation of VCP/p97 demonstrates the critical balance between cell death and epithelial-mesenchymal transition (EMT) downstream of ER stress , 2015, Oncotarget.
[64] W. Bamlet,et al. Antithetical NFATc1–Sox2 and p53–miR200 signaling networks govern pancreatic cancer cell plasticity , 2015, The EMBO journal.
[65] N. Kim,et al. Catabolic metabolism during cancer EMT , 2015, Archives of pharmacal research.
[66] G. von Heijne,et al. Tissue-based map of the human proteome , 2015, Science.
[67] Lars Juhl Jensen,et al. Cyclebase 3.0: a multi-organism database on cell-cycle regulation and phenotypes , 2014, Nucleic Acids Res..
[68] J. Mesirov,et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. , 2015, Cell systems.
[69] T. Ried,et al. CENP-A nucleosomes localize to transcription factor hotspots and subtelomeric sites in human cancer cells , 2015, Epigenetics & Chromatin.
[70] W. Earnshaw,et al. The Centromere: Chromatin Foundation for the Kinetochore Machinery , 2014, Developmental cell.
[71] S. Baylin,et al. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. , 2014, Molecular cell.
[72] Jie Fu,et al. Expression and prognostic relevance of centromere protein A in primary osteosarcoma. , 2014, Pathology, research and practice.
[73] G. Almouzni,et al. Mislocalization of the centromeric histone variant CenH3/CENP-A in human cells depends on the chaperone DAXX. , 2014, Molecular cell.
[74] Wei Shi,et al. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..
[75] Zhiwei Wang,et al. Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway , 2013, Oncotarget.
[76] A. Desai,et al. A two-step mechanism for epigenetic specification of centromere identity and function , 2013, Nature Cell Biology.
[77] K. Hua,et al. Prognostic value of centromere protein-A expression in patients with epithelial ovarian cancer , 2013, Tumor Biology.
[78] Rong Li,et al. Aneuploidy and chromosomal instability: a vicious cycle driving cellular evolution and cancer genome chaos , 2013, Cancer and Metastasis Reviews.
[79] N. Kim,et al. p53 regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer cells , 2013, Cell cycle.
[80] Peter W. Laird,et al. Interplay between the Cancer Genome and Epigenome , 2013, Cell.
[81] G. Berx,et al. Regulatory networks defining EMT during cancer initiation and progression , 2013, Nature Reviews Cancer.
[82] V. Rotter,et al. p53 Counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition , 2012, Cell Death and Differentiation.
[83] Xiao-Jun Feng,et al. Expression and prognostic significance of centromere protein A in human lung adenocarcinoma. , 2012, Lung cancer.
[84] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[85] J. Reis-Filho,et al. Epithelial and Mesenchymal Subpopulations Within Normal Basal Breast Cell Lines Exhibit Distinct Stem Cell/Progenitor Properties , 2012, Stem cells.
[86] Davis J. McCarthy,et al. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation , 2012, Nucleic acids research.
[87] Diego Miranda-Saavedra,et al. TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer , 2012, Nature Communications.
[88] Y. Qi,et al. Centromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer , 2012, Breast Cancer Research.
[89] B. E. Black,et al. HJURP is a CENP-A chromatin assembly factor sufficient to form a functional de novo kinetochore , 2011, The Journal of cell biology.
[90] P. Lambin,et al. E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[91] F. Real,et al. p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells , 2011, Cell cycle.
[92] Yongmei Li,et al. ShRNA-Targeted Centromere Protein A Inhibits Hepatocellular Carcinoma Growth , 2011, PloS one.
[93] M. Gerlinger,et al. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine , 2010, British Journal of Cancer.
[94] A. Clark,et al. Centromere protein A dynamics in human pluripotent stem cell self-renewal, differentiation and DNA damage , 2010, Human molecular genetics.
[95] K. Maehara,et al. CENP-A Reduction Induces a p53-Dependent Cellular Senescence Response To Protect Cells from Executing Defective Mitoses , 2010, Molecular and Cellular Biology.
[96] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[97] Ker-Chau Li,et al. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug , 2009, Nature Cell Biology.
[98] Yusuke Nakamura,et al. HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres , 2009, Cell.
[99] J. Yates,et al. Centromere-Specific Assembly of CENP-A Nucleosomes Is Mediated by HJURP , 2009, Cell.
[100] R. Maestro,et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. , 2008, Cancer cell.
[101] Douglas S. Darling,et al. Zeb1 links epithelial-mesenchymal transition and cellular senescence , 2008, Development.
[102] Th. Boveri. Concerning the Origin of Malignant Tumours by Theodor Boveri. Translated and annotated by Henry Harris , 2008, Journal of Cell Science.
[103] F. McKeon,et al. p63 Is Essential for the Proliferative Potential of Stem Cells in Stratified Epithelia , 2007, Cell.
[104] K. Choo,et al. Human centromere repositioning "in progress". , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[105] R. Salunga,et al. Gene expression profiles of human breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[106] Robert A. Weinberg,et al. Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation , 2002, Molecular and Cellular Biology.
[107] C. Tyler-Smith,et al. Transmission of a fully functional human neocentromere through three generations. , 1999, American journal of human genetics.